Antibiotic susceptibility and β‐lactamase production in clinical isolates of Enterobacter spp.
- 1 January 1990
- Vol. 98 (1-6) , 462-470
- https://doi.org/10.1111/j.1699-0463.1990.tb01058.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Evaluation of a disk approximation test of inducible beta‐lactamases in Enterobacteriacae and Pseudomonas aeruginosaAPMIS, 1989
- Ability of newer beta-lactam antibiotics to induce beta-lactamase production inEnterobacter cloacaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Clinical significance of beta-lactamase induction and stable derepression in gram-negative rodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Evaluation of disk approximation and agar dilution induction tests for demonstration of in vitro antagonism of cefotaxime by cefoxitin inEnterobacter speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine european laboratoriesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratoriesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patientsJournal of Antimicrobial Chemotherapy, 1986
- In Vitro Aminoglycoside Resistance of Gram-negative Bacilli and Staphylococci Isolated from Blood in Sweden 1980–1984Scandinavian Journal of Infectious Diseases, 1986
- In-vitro activity of BMY 28142, a new aminothiazolyl cephalosporinJournal of Antimicrobial Chemotherapy, 1985
- DISTURBANCES OF THE THYROID SEOEETION IN HOETHEEH MEXICOThe Lancet Healthy Longevity, 1970